Advertisement

Topics

Sustained Response to Direct-acting HCV Antivirals Tied to Lower HCC Risk

10:42 EDT 3 Jul 2017 | Medscape

A sustained virologic response to direct-acting antiviral treatment of hepatitis C (HCV) is associated with a “considerable” reduction in the risk of hepatocellular carcinoma (HCC), researchers say.
Reuters Health Information

Original Article: Sustained Response to Direct-acting HCV Antivirals Tied to Lower HCC Risk

NEXT ARTICLE

More From BioPortfolio on "Sustained Response to Direct-acting HCV Antivirals Tied to Lower HCC Risk"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...